Comparing the effectiveness constitutional Homoepathic medicine and Arsenicum album in treating Chronic Plaque Psoriasis.

“Study to assess the effectiveness of constitutional Homoepathic medicines in comparison with Arsenicum album in the treatment of Chronic Plaque Psoriasis in adult age group.“ - Nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/062665

Enrollment

Registered

2024-02-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Constitutional Homoeopathic Remedy: Constitutional Homoeopathic Remedy, 1M Potency Dose:One Dose for once in Every 15 days Duration of 6 months Route of Administration: Oral Control

Eligibility

Inclusion criteria

Inclusion criteria: Subjects aged between 20 to 60years. Both genders. Patients with clinical presentation of Chronic Plaque Psoriasis. Those subjects who are willing to take part in the study and sign the written informed consent.

Exclusion criteria

Exclusion criteria: Subjects on prolonged steroidal therapy, phototherapy, systemic therapy for psoriasis. Subjects having severe complications of psoriasis. Secondary infected lesions. Pregnant and lactating women.

Design outcomes

Secondary

Measure	Time frame
To know about Chronic Plaque Psoriasis with respect to its Definition Epidemiology Etiology Pathogenesis Clinical Features DiagnosisTimepoint: 6 months	—

Primary

Measure	Time frame
Assessing the effectiveness of constitutional Homoeopathic medicines in comparison with Arsenicum album in the treatment of Chronic Plaque Psoriasis in adult age groupTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Veerabhadrappa C

Parul University

kirtida.desai@paruluniversity.ac.in9574424363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026